| update on hepatitis c virus (hcv) infection. | | 1997 | 9816395 |
| transmission of hepatitis b and c viruses in outpatient settings--new york, oklahoma, and nebraska, 2000-2002. | transmission of hepatitis b virus (hbv) and hepatitis c virus (hcv) can occur in health-care settings from percutaneous or mucosal exposures to blood or other body fluids from an infected patient or health-care worker. this report summarizes the investigation of four outbreaks of hbv and hcv infections that occurred in outpatient health-care settings. the investigation of each outbreak suggested that unsafe injection practices, primarily reuse of syringes and needles or contamination of multiple ... | 2003 | 14508437 |
| a large nosocomial outbreak of hepatitis c and hepatitis b among patients receiving pain remediation treatments. | in august 2002, the oklahoma state department of health received a report of six patients with unexplained hepatitis c virus (hcv) infection treated in the same pain remediation clinic. we investigated the outbreak's extent and etiology. | 2004 | 15301030 |
| outcome of a hepatitis c outbreak among patients in a pain management clinic. | the aims of this study are to evaluate the natural history and response to therapy of patients following a hepatitis c outbreak in a pain management clinic. | 2010 | 20411419 |
| a cultural approach to conducting hiv/aids and hepatitis c virus education among native american adolescents. | this pilot study tests the feasibility of using a talking circle approach and measures cultural values and beliefs within a hiv/aids and hepatitis c virus (hcv) prevention program conducted among a native american (cherokee) youth population. a descriptive correlation design was used to examine the relationship between cherokee self-reliance and hiv/aids and hcv knowledge, attitudes, and behaviors. the study used three questionnaires that were administered before and after the prevention program ... | 2008 | 18757356 |
| the oklahoma-pittsburgh experience with interferon alpha in the treatment of hcv disease. | interferon alpha (ifn) is the only food and drug administration (fda)-approved therapy available for the treatment of chronic hepatitis c. the ideal dose and frequency of ifn administration that produces the greatest number of patient responders with the least number of relapses following drug withdrawal remains unclear. methods. one hundred seventeen patients recruited over a five-year period with chronic hepatitis c were divided into four groups and treated with progressively larger doses. the ... | 1995 | 7782963 |